Lameness in Ruminants Conference 2024

More than 115 submitted abstracts

A special thanks to all the Authors for their contribution!

All abstracts have been forwarded to the Scientific Committee for review.

Important Date
Event	Date
Notification to Authors	30 June 2024

SCIENTIFIC COMMITTEE CHAIRS

Carlo Maria Mortellaro
DVM, Former Full Professor of Surgical Veterinary Pathophysiology, Dept. of Veterinary Surgery, Veterinary School, University of Milan (Italy)

Loris De Vecchis
DVM, Contract professor Veterinary School, University of Milan (Italy)

Matteo Gianesella
DVM, PhD, Full Prof. Internal Medicine. Department of Animal Medicine, Production and Health. President School of Agricultural Sciences and Veterinary Medicine. University of Padua (Italy)

Evaluation of the Abstract

The evaluation will be carried out considering:

potential scientific value and relevance of the study,
the originality of the study,
clear description of the study,
relation of the methodology with the objectives,
congruence between results and conclusions,
ethical considerations,
correct writing in the English language.

All abstracts are reviewed by the Congress Scientific Committee which reserves the right to select abstracts relevant to the sessions and topics and decides on the final form of the presentation (oral or poster).

The contact author will be notified as of June 30^th, 2024 if the abstract has been accepted. Notifications will be sent by e-mail to the addresses indicated during abstract submission. Together with the notification, if the abstract is selected for poster or oral presentation.

The Oral presentation must be presented in English and will have a 15-minute slot (including 3 min for questions/answers) which may not be exceeded.

Manuscripts must contain scientific data and meet international ethical standards.

EV POLICY ON THE USE OF ANIMALS IN RESEARCH

EV’s aims are to promote and advance the standards in veterinary species through clinical research and training. We encourage robust clinical and translational research in the area of veterinary podiatry.

Such research may often involve prospective or retrospective studies on animals or ex vivo or in vitro studies on animal tissues. Studies on veterinary patients should not involve unnecessary interventions with the sole purpose of research; in other words, all interventions on veterinary patients should be for the intended benefit of the individual animal.

All such research should have local Ethics Committee approval as well as any local, regional or national licences when required; abstracts submitted should state this is the case when indicated.

As society concerned with the health and welfare of animals, EV acknowledges that sometimes research on animals is necessary for the benefit of human and animal health. However, we strongly support the 3R tenets of Russell and Burch, namely ‘replacement, refinement and reduction’ of animals in research, as supported by the International Council for Laboratory Animal Science (www.iclas.org) and embedded in the European Union Directive 2010/63/EU

(https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF)

Moreover, EV will not accept any studies for presentation or publication that involve the use of live bovines and small ruminants, dogs, cats, horses or non-human primates in invasive experimentation.